Protagenic Therapeutics Inc. (PTIX)

[arnesar]

According to their unaudited 10-Q for the quarter ending September 30, 2011:

• $14M in assets ($9M current) vs. $19.7M in liabilities ($18.8M current);
• $182.2M accumulated deficit;
• $12.3M in net revenue for the quarter;
• $4.5M net loss for the quarter.

Let's hope that the stock will be able to locate price support in its current range and that ATRN's management can find an amicable solution to the issues that are affecting the stock's performance for the benefit of their shareholders.



ATRN